Suchergebnisse - (Person:"Prentice, Ralley E")

PubPharm (20)

1

Letter : Transperineal ultrasonography for ulcerative proctitis- Applicability in the pregnant population?

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Greeve, T. | Prentice, R. | Shelton, E. | +3

CommentOn: Aliment Pharmacol Ther. 2022 May;55(10):1320-1329. - PMID 35218038

2

Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility

enthalten in: European journal of gastroenterology & hepatology | 2023

von Prentice, R. | Wright, E. | Flanagan, E. | +5

3

The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function

enthalten in: Cellular and molecular gastroenterology and hepatology | 2023

von Prentice, R. | Wright, E. | Flanagan, E. | +6

4

Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists : Barriers and Areas for Improvement

enthalten in: Inflammatory bowel diseases | 2022

von Christensen, B. | Prentice, R. | Al-Ani, A. | +3

5

Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19-Balancing Risks of Delayed Treatment Recommencement

enthalten in: Journal of Crohn's & colitis | 2022

von Prentice, R. | Ross, A. | Flanagan, E.

CommentOn: J Crohns Colitis. 2020 Oct 21;14(14 Suppl 3):S807-S814. - PMID 33085970

6

Safety of in utero exposure to maternal IBD pharmacotherapies

enthalten in: Nature reviews. Gastroenterology & hepatology | 2022

von Prentice, R. | Bell, S. | Nold-Petry, C. | +2

7

SARS-CoV-2 vaccination in patients with inflammatory bowel disease

enthalten in: GastroHep | 2021

von Prentice, R. | Rentsch, C. | Al-Ani, A. | +10

8

Letter : colorectal cancer surveillance in inflammatory bowel disease-a call for systematic reform

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Prentice, R. | Hollingsworth, L. | Middleton, C. | +1

CommentOn: Aliment Pharmacol Ther. 2021 Jan;53(2):291-301. - PMID 33159472

9

Letter : SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Al-Ani, A. | Prentice, R. | Rentsch, C. | +1

CommentOn: Aliment Pharmacol Ther. 2021 Mar;53(6):764-765. - PMID 33599328

10

Managing COVID-19 in patients with inflammatory bowel disease : navigating unprecedented challenges

enthalten in: Internal medicine journal | 2021

von Prentice, R. | Al-Ani, A. | Christensen, B.